Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP273807.RAfyI9uexPwQVX_V39ps3Ed0ORnxjjdJ0xvPBR2OQnjOo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP273807.RAfyI9uexPwQVX_V39ps3Ed0ORnxjjdJ0xvPBR2OQnjOo130_assertion type Assertion NP273807.RAfyI9uexPwQVX_V39ps3Ed0ORnxjjdJ0xvPBR2OQnjOo130_head.
- NP273807.RAfyI9uexPwQVX_V39ps3Ed0ORnxjjdJ0xvPBR2OQnjOo130_assertion description "[Several of these variants are in or near genes with a biological rationale for conferring EOC risk, including ZFP36L1 and RAD51B for mucinous EOC (rs17106154, OR�=�1.17, P�=�0.029, n�=�1,483 cases), GRB10 for endometrioid and clear cell EOC (rs2190503, P�=�0.014, n�=�2,903 cases), and C22orf26/BPIL2 for LMP serous EOC (rs9609538, OR�=�0.86, P�=�0.0043, n�=�892 cases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP273807.RAfyI9uexPwQVX_V39ps3Ed0ORnxjjdJ0xvPBR2OQnjOo130_provenance.
- NP273807.RAfyI9uexPwQVX_V39ps3Ed0ORnxjjdJ0xvPBR2OQnjOo130_assertion evidence source_evidence_literature NP273807.RAfyI9uexPwQVX_V39ps3Ed0ORnxjjdJ0xvPBR2OQnjOo130_provenance.
- NP273807.RAfyI9uexPwQVX_V39ps3Ed0ORnxjjdJ0xvPBR2OQnjOo130_assertion SIO_000772 24190013 NP273807.RAfyI9uexPwQVX_V39ps3Ed0ORnxjjdJ0xvPBR2OQnjOo130_provenance.
- NP273807.RAfyI9uexPwQVX_V39ps3Ed0ORnxjjdJ0xvPBR2OQnjOo130_assertion wasDerivedFrom befree-20150227 NP273807.RAfyI9uexPwQVX_V39ps3Ed0ORnxjjdJ0xvPBR2OQnjOo130_provenance.
- NP273807.RAfyI9uexPwQVX_V39ps3Ed0ORnxjjdJ0xvPBR2OQnjOo130_assertion wasGeneratedBy ECO_0000203 NP273807.RAfyI9uexPwQVX_V39ps3Ed0ORnxjjdJ0xvPBR2OQnjOo130_provenance.